Accelerating Drug Disocvery & Development
From early-stage molecule design to formulation optimization, Juzay leverages AI, machine learning, and computational modeling to make your drug development smarter, faster, and more reliable.
Our Solutions
Our comprehensive suite of AI-powered services accelerates every stage of the drug discovery & development, from hit identification to formulation and registration.
Revolutionizing Drug Discovery & Development with AI
Our proprietary platform utilize AI to overcome traditional drug discovery & development bottlenecks.
AI-Enhanced Activity Prediction
Predict compound biological activities using custom-developed models based on customers datasets using advanced machine learning algorithms.
AI-Powered ADMET Prediction
Leverage our accurate models to predict key physicochemical and ADMET properties.
AI-Based Decision Support
Our AI models are used to support decisions during drug development.
Proven Results & Case Studies
Our platform has delivered measurable success across multiple therapeutic areas, accelerating drug discovery & development for our partners.
By The Numbers
16
Highly accurate developed ADMET models
Up to 95%
Predictions accuracy
> 85,000
Compounds used in training models
Peer-Reviewed Validation
Our technology has been validated in multiple publications in leading scientific journals including PLOS Digital Health and Journal of Computational Chemistry.
Our Mission & Vision
Mission
"To empower researchers and pharmaceutical industry by accelerating early-stage drug discovery using cutting-edge computational approaches."
Vision
"To become a trusted platform for computational drug discovery, bridging data, AI, and chemistry to design safer and more effective therapeutics faster than ever before."
Ready to Transform Your Drug Discovery?
Contact us to discuss how our AI-powered platform can accelerate your therapeutic programs and increase your chances of success.
Customized Solutions
Tailored approaches for your specific therapeutic area, target class, and discovery / development challenges.
Proprietary Technology
Access to our cutting-edge AI models, molecular libraries, and expert scientific team.